"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Penicilline","Ampicillina",6073,"1.1","0.8","1.4"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Aminoglicosidi (alto dosaggio)","Gentamicina",3028,"37.3","35.6","39.1"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Aminoglicosidi (alto dosaggio)","Streptomicina",3833,"34.4","32.9","36.0"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Glicopeptidi","Vancomicina",6189,"1.5","1.2","1.9"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Glicopeptidi","Teicoplanina",6027,"1.6","1.3","2.0"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2020.pdf","Ossazolidinioni","Linezolid",6026,"0.5","0.4","0.7"
